HIF1A and breast carcinoma: Among the studies where the predictive value of HIF-1α in breast cancer is evaluated, very few have investigated the relation between the expression of HIF-1α and pCR or the predictive value of the molecule in breast cancer patients going under neoadjuvant chemotherapy based on anthracyclines and taxanes [26,27,28,29,30,31].